Skip to main content
SpringerLink
Log in

Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors

  • Chapter
  • First Online:
Renal Cell Carcinoma

Part of the book series: Current Clinical Urology ((CCU))

Abstract

The worldwide incidence of kidney cancer has been increasing for many years likely as a consequence of numerous factors, including the increased utilization of abdominal imaging with an increased incidental diagnosis of small renal tumors, the aging of the population, and the increased prevalence of environmental and lifestyle risk factors for renal cell carcinoma (RCC). A wide variability in geographic, gender, and ethnic differences has been observed relative to RCC around the world, with tobacco use, obesity, and hypertension emerging as the primary environmental factors that predispose to RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization (WHO). Globocan 2008. Cancer incidence and mortality worldwide; 2008. http://globocan.iarc.fr/. Accessed Nov 2010.

  2. Devesa SS, Silverman DT, McLaughlin JK, Brown CC, Connelly RR, Fraumeni Jr JF. Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control. 1990;1(2):133–41.

    Article  PubMed  CAS  Google Scholar 

  3. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973–2002), National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission; 2005.

    Google Scholar 

  4. Mathew A, Devesa SS, Fraumeni Jr JF, Chow WH. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev. 2002;11(2):171–8.

    Article  PubMed  CAS  Google Scholar 

  5. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331–4.

    Article  PubMed  Google Scholar 

  6. Chow WH, Linehan WM, Devesa SS. Re: rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2007;99(7):569–70 [author reply 570–1].

    Article  PubMed  Google Scholar 

  7. American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010.

    Google Scholar 

  8. Sun M, Thuret R, Abdollah F, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41.

    Article  PubMed  Google Scholar 

  9. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer statistics review, 1975–2007. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/. Accessed Nov 2010.

  10. Chow WH, Devesa SS, Warren JL, Fraumeni Jr JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628–31.

    Article  PubMed  CAS  Google Scholar 

  11. IMV Medical Information Division. CT census database and market summary report. Greenbelt; MD IMV2008.

    Google Scholar 

  12. Amis Jr ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007;4(5):272–84.

    Article  PubMed  Google Scholar 

  13. Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol. 1983;34(4):437–9.

    Article  PubMed  CAS  Google Scholar 

  14. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology. 2000;215(2):353–7.

    PubMed  CAS  Google Scholar 

  15. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288–301.

    Article  PubMed  CAS  Google Scholar 

  16. World Health Organization (WHO). Fact sheet N311. Obesity and overweight; 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.

  17. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.

    PubMed  Google Scholar 

  18. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.

    Article  PubMed  Google Scholar 

  19. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101(8):949–58.

    Article  PubMed  Google Scholar 

  20. Levi F, Lucchini F, Negri E, La Vecchia C. Declining mortality from kidney cancer in Europe. Ann Oncol. 2004;15(7):1130–5.

    Article  PubMed  CAS  Google Scholar 

  21. Vaishampayan UN, Do H, Hussain M, Schwartz K. Racial disparity in incidence patterns and outcome of kidney cancer. Urology. 2003;62(6):1012–7.

    Article  PubMed  CAS  Google Scholar 

  22. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372–7.

    Article  PubMed  CAS  Google Scholar 

  23. Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. Available from: http://0-www.ncbi.nlm.nih.gov.elis.tmu.edu.tw/books/NBK53017/.

  24. Thakker DR, Yagi H, Levin W, Wood AW, Conney AH, Jerina DM. Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Anders MW, editor. Bioactivation of foreign compounds. New York: Academic; 1985. p. 177–242.

    Google Scholar 

  25. Zhu Y, Horikawa Y, Yang H, Wood CG, Habuchi T, Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J Urol. 2008;179(6):2416–21.

    Article  PubMed  Google Scholar 

  26. Shiao YH, Rice JM, Anderson LM, Diwan BA, Hard GC. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J Natl Cancer Inst. 1998;90(22):1720–3.

    Article  PubMed  CAS  Google Scholar 

  27. Swann PF, Kaufman DG, Magee PN, Mace R. Induction of kidney tumours by a single dose of dimethylnitrosamine: dose response and influence of diet and benzo(a)pyrene pretreatment. Br J Cancer. 1980;41(2):285–94.

    Article  PubMed  CAS  Google Scholar 

  28. Clague J, Shao L, Lin J, et al. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis. 2009;30(4):706–10.

    Article  PubMed  CAS  Google Scholar 

  29. IARC monographs on the evaluation of carcinogenic risks to humans tobacco smoke and involuntary smoking, vol 83. Lyon: World Health Organization International Agency for Research on Cancer; 2004. p. 339–70. Available from: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=72&codcch=83.

  30. US Department of Health and Human Services. The health consequence of smoking: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.

    Google Scholar 

  31. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114(1):101–8.

    Article  PubMed  CAS  Google Scholar 

  32. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100–10.

    Article  PubMed  CAS  Google Scholar 

  33. Sweeney C, Farrow DC. Differential survival related to smoking among patients with renal cell carcinoma. Epidemiology. 2000;11(3):344–6.

    Article  PubMed  CAS  Google Scholar 

  34. Parker A, Lohse C, Cheville J, Leibovich B, Igel T, Blute M. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol. 2008;15(4):304–8.

    Article  PubMed  Google Scholar 

  35. Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol. 2010;28(26):4058–65.

    Article  PubMed  Google Scholar 

  36. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211–23.

    Article  PubMed  CAS  Google Scholar 

  37. Pantuck AJ, Seligson DB, Klatte T, et al. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer. 2007;109(11):2257–67.

    Article  PubMed  CAS  Google Scholar 

  38. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356(22):2271–81.

    Article  PubMed  CAS  Google Scholar 

  39. Motzer RJ, Escudier B, Oudard S, et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors. Cancer. 2010;116(18):4256–65.

    Article  PubMed  CAS  Google Scholar 

  40. Masur K, Vetter C, Hinz A, et al. Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer. 2011;104(2):345–52.

    Article  PubMed  CAS  Google Scholar 

  41. Mussig K, Haring HU. Insulin signal transduction in normal cells and its role in carcinogenesis. Exp Clin Endocrinol Diabetes. 2010;118(6):356–9.

    Article  PubMed  CAS  Google Scholar 

  42. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12): 915–28.

    Article  PubMed  CAS  Google Scholar 

  43. Takahashi K, Suzuki K. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int J Cancer. 1993;55(3):453–8.

    Article  PubMed  CAS  Google Scholar 

  44. Klatte T, Said JW, de Martino M, et al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol. 2009;181(4):1558–64 [discussion 1563–4].

    Article  PubMed  Google Scholar 

  45. Noon AP, Vlatkovic N, Polanski R, et al. p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets? Cancer. 2010;116(4):780–90.

    Article  PubMed  CAS  Google Scholar 

  46. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836–46.

    Article  PubMed  CAS  Google Scholar 

  47. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010;31(1):83–9.

    Article  PubMed  CAS  Google Scholar 

  48. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108(1):115–21.

    Article  PubMed  CAS  Google Scholar 

  49. Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the european prospective investigation into cancer and nutrition (EPIC) study. Eur J Cancer. 2010;46(14):2555–62.

    Article  PubMed  Google Scholar 

  50. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9 Suppl 4:228S–33.

    Article  PubMed  Google Scholar 

  51. Sawada N, Inoue M, Sasazuki S, et al. Body mass index and subsequent risk of kidney cancer: a prospective cohort study in Japan. Ann Epidemiol. 2010;20(6):466–72.

    Article  PubMed  Google Scholar 

  52. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;118(3):728–38.

    Article  PubMed  CAS  Google Scholar 

  53. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91.

    Article  PubMed  CAS  Google Scholar 

  54. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010;105(1):16–20.

    Article  PubMed  Google Scholar 

  55. Lee JE, Mannisto S, Spiegelman D, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev. 2009;18(6): 1730–9.

    Article  PubMed  CAS  Google Scholar 

  56. Lindblad P, Wolk A, Bergstrom R, Adami HO. Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6(4):215–23.

    PubMed  CAS  Google Scholar 

  57. Weikert S, Boeing H, Pischon T, et al. Fruits and vegetables and renal cell carcinoma: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;118(12):3133–9.

    Article  PubMed  CAS  Google Scholar 

  58. Allen NE, Roddam AW, Sieri S, et al. A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2009;125(4):982–7.

    Article  PubMed  CAS  Google Scholar 

  59. Lee JE, Spiegelman D, Hunter DJ, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst. 2008;100(23):1695–706.

    Article  PubMed  CAS  Google Scholar 

  60. Mellemgaard A, McLaughlin JK, Overvad K, Olsen JH. Dietary risk factors for renal cell carcinoma in Denmark. Eur J Cancer. 1996;32A(4):673–82.

    Article  PubMed  CAS  Google Scholar 

  61. Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2445–52.

    Article  PubMed  CAS  Google Scholar 

  62. Hu J, Mao Y, White K. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control. 2003;14(8):705–14.

    Article  PubMed  Google Scholar 

  63. Wolk A, Gridley G, Niwa S, et al. International renal cell cancer study. VII. Role of diet. Int J Cancer. 1996;65(1):67–73.

    Article  PubMed  CAS  Google Scholar 

  64. Wolk A, Larsson SC, Johansson JE, Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA. 2006;296(11):1371–6.

    Article  PubMed  CAS  Google Scholar 

  65. Lee JE, Hunter DJ, Spiegelman D, et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst. 2007;99(10): 801–10.

    Article  PubMed  Google Scholar 

  66. Chiu BC, Gapstur SM, Chow WH, Kirby KA, Lynch CF, Cantor KP. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond). 2006;30(6):940–7.

    Article  Google Scholar 

  67. Moore SC, Chow WH, Schatzkin A, et al. Physical activity during adulthood and adolescence in relation to renal cell cancer. Am J Epidemiol. 2008;168(2):149–57.

    Article  PubMed  Google Scholar 

  68. Bergstrom A, Terry P, Lindblad P, et al. Physical activity and risk of renal cell cancer. Int J Cancer. 2001;92(1):155–7.

    Article  PubMed  CAS  Google Scholar 

  69. Waalkes S, Merseburger AS, Kramer MW, et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control. 2010;21(11):1905–10.

    Article  PubMed  Google Scholar 

  70. Haferkamp A, Pritsch M, Bedke J, et al. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int. 2008;101(10):1243–6.

    Article  PubMed  Google Scholar 

  71. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006;68(4):741–6.

    Article  PubMed  Google Scholar 

  72. Andreotti G, Boffetta P, Rosenberg PS, et al. Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis. 2010;31(4):614–20.

    Article  PubMed  CAS  Google Scholar 

  73. Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis. 2004;7(3): 193–201.

    Article  PubMed  CAS  Google Scholar 

  74. Chow WH, Gridley G, Fraumeni Jr JF, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305–11.

    Article  PubMed  CAS  Google Scholar 

  75. Flaherty KT, Fuchs CS, Colditz GA, et al. A ­prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16(9): 1099–106.

    Article  PubMed  Google Scholar 

  76. Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(4):438–46.

    Article  PubMed  Google Scholar 

  77. Vatten LJ, Trichopoulos D, Holmen J, Nilsen TI. Blood pressure and renal cancer risk: the HUNT Study in Norway. Br J Cancer. 2007;97(1):112–4.

    Article  PubMed  CAS  Google Scholar 

  78. Weikert S, Ljungberg B. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol. 2010;28(3):247–52.

    Article  PubMed  Google Scholar 

  79. Corrao G, Scotti L, Bagnardi V, Sega R. Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis. Curr Drug Saf. 2007;2(2):125–33.

    Article  PubMed  Google Scholar 

  80. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149(6):521–30.

    Article  PubMed  CAS  Google Scholar 

  81. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995;63(2):216–21.

    Article  PubMed  CAS  Google Scholar 

  82. Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67(2):647–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, David Geffen School of Medicine, Institute of Urologic Oncology, University of California-Los Angeles, 924 Westwood Boulevard, Suite 1050, Los Angeles, CA, 90095-7207, USA

    Frédéric D. Birkhäuser MD, Nils Kroeger MD & Allan J. Pantuck MD, MS, FACS

Authors
  1. Frédéric D. Birkhäuser MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nils Kroeger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allan J. Pantuck MD, MS, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allan J. Pantuck MD, MS, FACS .

Editor information

Editors and Affiliations

  1. Glickman Urological and Kidney Institute, Center for Urologic Oncology, Cleveland Clinic, Cleveland, 44195, Ohio, USA

    Steven C. Campbell

  2. College of Medicine, Case Western Reserve University, Cleveland Clinic Lerner, Department of Solid Tumor Oncology, Cleveland, 44195, Ohio, USA

    Brian I. Rini

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Birkhäuser, F.D., Kroeger, N., Pantuck, A.J. (2013). Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors. In: Campbell, S., Rini, B. (eds) Renal Cell Carcinoma. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-062-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-062-5_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-061-8

  • Online ISBN: 978-1-62703-062-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation